Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway

被引:20
|
作者
Giatromanolaki, Alexandra [1 ,2 ,3 ]
Koukourakis, Michael I. [1 ,2 ,3 ]
Pezzella, Francesco [4 ,5 ]
Turley, Helen [4 ,5 ]
Sivridis, Efthimlos [1 ,2 ,3 ]
Bouros, Demosthenes [1 ,2 ,3 ]
Bougioukas, George [1 ,2 ,3 ]
Harris, Adrian L. [4 ,5 ]
Gatter, Kevin C. [4 ,5 ]
机构
[1] Democritus Univ Thrace, Dept Pathol, Alexandroupolis 68100, Greece
[2] Democritus Univ Thrace, Dept Radiotherapy Oncol, Alexandroupolis 68100, Greece
[3] Democritus Univ Thrace, Dept Pneumol & Thorac Surg, Alexandroupolis 68100, Greece
[4] John Radcliffe Hosp, Canc Res UK Mol Oncol Lab, Inst Mol Med, Oxford OX3 9DU, England
[5] Univ Oxford, Nuffield Dept, Clin Sci Lab, Oxford OX3 9DU, England
关键词
lung cancer; hypoxia inducible factors; prolyl-hydroxylases; asparagine hydroxylases; lactate dehydrogenase;
D O I
10.1016/j.canlet.2007.11.041
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The oxygen sensitive prolyl-hydroxylase domain enzymes (PHDs) and the asparagines hydroxylase (FIH, factor inhibiting HIF) regulate the transcriptional activity of HIFs. We assessed the expression of these enzymes in a series of 73 non-small cell lung carcinomas (NSCLC). A direct association of PHDs with FIH and of the PHDs/FIH with HIFs expression was noted. Thirty three of 73 cases had high HIF/PHD expression, predicting intense HIF activity; 19/73 cases had low H IF and high PHD expression mimicking the normal bronchial pattern-, and 18/73 cases had low HIF/PHD (inactive HIF pathway). High lactate dehydrogenase LDH5 expression was noted in cases with high HIF/PHD phenotype. The value of such a classification in defining different metabolic phenotypes of NSCLC deserves further evaluation. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:87 / 93
页数:7
相关论文
共 50 条
  • [1] Expression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer
    Agnieszka A Rawluszko
    Katarzyna E Bujnicka
    Karolina Horbacka
    Piotr Krokowicz
    Paweł P Jagodziński
    BMC Cancer, 13
  • [2] Expression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer
    Rawluszko, Agnieszka A.
    Bujnicka, Katarzyna E.
    Horbacka, Karolina
    Krokowicz, Piotr
    Jagodzinski, Pawel P.
    BMC CANCER, 2013, 13
  • [3] Expression of key hypoxia sensing prolyl-hydroxylases PHD1,-2 and-3 in pancreaticobiliary cancer
    Gossage, Lucy
    Zaitoun, Abed
    Fareed, Khaleel R.
    Turley, Helen
    Aloysius, Mark
    Lobo, Dileep N.
    Harris, Adrian L.
    Madhusudan, Srinivasan
    HISTOPATHOLOGY, 2010, 56 (07) : 908 - 920
  • [4] Prolyl hydroxylase domain enzyme PHD2 inhibits proliferation and metabolism in non-small cell lung cancer cells in HIF-dependent and HIF-independent manners
    Deng, Hongyan
    Wang, Zixuan
    Zhu, Chunchun
    Chen, Zhu
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [5] DNA methylation analysis of the HIF-1α prolyl hydroxylase domain genes PHD1, PHD2, PHD3 and the factor inhibiting HIF gene FIH in invasive breast carcinomas
    Huang, Katie T.
    Mikeska, Thomas
    Dobrovic, Alexander
    Fox, Stephen B.
    HISTOPATHOLOGY, 2010, 57 (03) : 451 - 460
  • [6] Prognosis value of HIF-1α expression in patients with non-small cell lung cancer
    Wang, Qian
    Hu, Dan-feng
    Rui, Yan
    Jiang, An-bang
    Liu, Zi-li
    Huang, Li-nian
    GENE, 2014, 541 (02) : 69 - 74
  • [7] Expression of prolyl 4-hydroxylase beta-polypeptide in non-small cell lung cancer treated with Chinese medicines
    Shu-mei Wang
    Li-zhu Lin
    Dai-han Zhou
    Jing-xu Zhou
    Shao-quan Xiong
    Chinese Journal of Integrative Medicine, 2015, 21 : 689 - 696
  • [8] Expression of Prolyl 4-Hydroxylase Beta-Polypeptide in Non-Small Cell Lung Cancer Treated with Chinese Medicines
    Wang Shu-mei
    Lin Li-zhu
    Zhou Dai-han
    Zhou Jing-xu
    Xiong Shao-quan
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2015, 21 (09) : 689 - 696
  • [9] Expression of Prolyl 4-Hydroxylase Beta-Polypeptide in Non-Small Cell Lung Cancer Treated with Chinese Medicines
    王淑美
    林丽珠
    周岱翰
    周京旭
    熊绍权
    Chinese Journal of Integrative Medicine, 2015, 21 (09) : 689 - 696
  • [10] The expression of prolyl hydroxylase domain enzymes are up-regulated and negatively correlated with Bcl-2 in non-small cell lung cancer
    Chen, Sufeng
    Zhang, Jie
    Li, Xuebing
    Luo, Xiaoyang
    Fang, Jing
    Chen, Haiquan
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2011, 358 (1-2) : 257 - 263